[Federal Register Volume 85, Number 89 (Thursday, May 7, 2020)]
[Notices]
[Page 27226]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09723]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meeting

AGENCY: Agency for Healthcare Research and Quality, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act, announcement is made of an Agency for Healthcare 
Research and Quality (AHRQ) Special Emphasis Panel (SEP) meeting on 
AHRQ-HS-20-001, ``Improving Management of Opioids and Opioid Use 
Disorder (OUD) in Older Adults (R18).'' This SEP meeting will be closed 
to the public.

DATES: May 29, 2020.

ADDRESSES: Agency for Healthcare Research and Quality (Virtual Review), 
5600 Fishers Lane, Rockville, Maryland 20850.

FOR FURTHER INFORMATION CONTACT: Anyone wishing to obtain a roster of 
members, agenda or minutes of the non-confidential portions of this 
meeting should contact: Jenny Griffith, Acting Committee Management 
Officer, Office of Extramural Research, Education and Priority 
Populations, AHRQ, 5600 Fishers Lane, Rockville, Maryland 20850, 
Telephone: (301) 427-1557.
    Agenda items for this meeting are subject to change as priorities 
dictate.

SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of 
experts in fields related to health care research who are invited by 
the Agency for Healthcare Research and Quality (AHRQ), and agree to be 
available, to conduct on an as needed basis, scientific reviews of 
applications for AHRQ support. Individual members of the Panel do not 
attend regularly-scheduled meetings and do not serve for fixed terms or 
a long period of time. Rather, they are asked to participate in 
particular review meetings which require their type of expertise.
    The SEP meeting referenced above will be closed to the public in 
accordance with the provisions set forth in 5 U.S.C. App. 2, section 
10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications 
for the AHRQ-HS-20-001, ``Improving Management of Opioids and Opioid 
Use Disorder (OUD) in Older Adults (R18)'' is to be reviewed and 
discussed at this meeting. The grant applications and the discussions 
could disclose confidential trade secrets or commercial property such 
as patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Dated: May 1, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020-09723 Filed 5-6-20; 8:45 am]
 BILLING CODE 4160-90-P